Risk factor | n | Events, n (%) | All-cause mortality HR (95% Cl), P Value | |
---|---|---|---|---|
Univariate | Multivariatea | |||
Albumin, g/L | Â | Â | Â | Â |
Continuous | Â | Â | Â | Â |
IQR (33.9–39.2) | 1449 | 107 (7.4%) | 0.86 (0.83–0.91), < 0.001 | 0.90 (0.85–0.95), < 0.001 |
Categories | Â | Â | Â | Â |
Group 1 (≥ 35) | 948 | 46 (4.9%) | Ref | Ref |
Group 2 (< 35) | 501 | 61 (12.2%) | 2.49 (1.69–3.66), < 0.001 | 1.93 (1.20–3.08), 0.006 |
Tertiles (min–max) |  |  |  |  |
T3 (38.1–64.3) | 472 | 15 (3.2%) | Ref | Ref |
T2 (34.8–38.1) | 488 | 35 (7.2%) | 2.15 (1.17–3.95), 0.014 | 1.73 (0.86–3.49), 0.12 |
T1 (18.7—34.8) | 474 | 57 (12.0%) | 3.69 (2.08–6.52), < 0.001 | 2.55 (1.29–5.02), 0.007 |
P for trend |  |  |  < 0.001 | 0.005 |
hs-CRP, mg/L | Â | Â | Â | Â |
Continuous | Â | Â | Â | Â |
IQR (0.96–9.1) | 1449 | 107 (7.4%) | 1.01 (1.00–1.01), < 0.001 | 1.00 (1.00–1.01), 0.18 |
log10 (hs-CRP) | 1449 | 107 (7.4%) | 1.72 (1.31–2.26), < 0.001 | 1.51 (1.09–2.09), 0.014 |
Categories | Â | Â | Â | Â |
Group 1 (≤ 3) | 716 | 29 (4.1%) | Ref | Ref |
Group 1 (> 3) | 731 | 78 (10.7%) | 2.60 (1.69–3.99), < 0.001 | 2.49 (1.48–4.17), < 0.001 |
Tertiles (min–max) |  |  |  |  |
T1 (0.18–1.4) | 481 | 23 (4.8%) | Ref | Ref |
T2 (1.4–6.0) | 481 | 27 (5.6%) | 1.23 (0.71–2.15), 0.46 | 1.52 (0.81–2.88), 0.20 |
T3 (6.0–194) | 485 | 57 (11.8%) | 2.41 (1.48–3.93), < 0.001 | 2.10 (1.17–3.78), 0.013 |
P for trend |  |  |  < 0.001 | 0.013 |